Cargando…
A novel cell-free single-molecule unique primer extension resequencing (cf-SUPER) technology for bladder cancer non-invasive detection in urine
BACKGROUND: The clinical diagnostic method for bladder cancer is cystoscopy, an invasive, expensive and inconvenient clinical test. Using urinary cell-free DNA (cfDNA) to develop non-invasive test for bladder cancer was a promising liquid biopsy. METHODS: To improve the using rate of cfDNA template...
Autores principales: | Zhao, Cheng, Pan, Yi, Wang, Yinhuai, Li, Yuanwei, Han, Weiqing, Lu, Li, Tang, Wei, Li, Pei, Ou, Zhenyu, Zhang, Mengda, Xiong, Zhuang, Xu, Ran, Lu, Qiang, Xu, Zhenzhou, Qi, Lin, Wang, Long, Xu, Genming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354286/ https://www.ncbi.nlm.nih.gov/pubmed/32676405 http://dx.doi.org/10.21037/tau-19-774 |
Ejemplares similares
-
Evaluation of the arrayed primer extension resequencing assay for TP53 mutation detection
por: Due, EU, et al.
Publicado: (2005) -
Urine Cellular DNA Point Mutation and Methylation for Identifying Upper Tract Urinary Carcinoma
por: Ouyang, Wei, et al.
Publicado: (2022) -
CF Patient’s Pneumothoraxes Unique Genes
por: McKee, Jillian, et al.
Publicado: (2016) -
Whole-Genome Resequencing Highlights the Unique Characteristics of Kecai Yaks
por: Kang, Yandong, et al.
Publicado: (2022) -
A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma
por: Zhang, Junjie, et al.
Publicado: (2023)